| Targeting CDK9 reactivates epigenetically silenced genes in cancer H Zhang, S Pandey, M Travers, H Sun, G Morton, J Madzo, W Chung, ... Cell 175 (5), 1244-1258. e26, 2018 | 202 | 2018 |
| Frizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells GE Simmons Jr, S Pandey, A Nedeljkovic-Kurepa, M Saxena, A Wang, ... PloS one 9 (6), e98861, 2014 | 57 | 2014 |
| A novel MeCP2 acetylation site regulates interaction with ATRX and HDAC1 S Pandey, GE Simmons Jr, S Malyarchuk, TN Calhoun, K Pruitt Genes & cancer 6 (9-10), 408, 2015 | 32 | 2015 |
| Functional assessment of MeCP2 in Rett syndrome and cancers of breast, colon, and prostate S Pandey, K Pruitt Biochemistry and Cell Biology 95 (3), 368-378, 2017 | 13 | 2017 |
| Selective CDK9 inhibition by natural compound toyocamycin in cancer cells S Pandey, R Djibo, A Darracq, G Calendo, H Zhang, RA Henry, ... Cancers 14 (14), 3340, 2022 | 11 | 2022 |
| Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer S Modi, B Giri, VK Gupta, S Lavania, V Sethi, NS Sharma, S Pandey, ... Cancer letters 537, 215591, 2022 | 9 | 2022 |
| Identification of novel MeCP2 cancer-associated target genes and post-translational modifications I Castro-Piedras, D Vartak, M Sharma, S Pandey, L Casas, D Molehin, ... Frontiers in Oncology 10, 576362, 2020 | 8 | 2020 |
| Role of epigenetics in pancreatic ductal adenocarcinoma S Pandey, VK Gupta, SP Lavania Epigenomics 15 (2), 89-110, 2023 | 5 | 2023 |
| Racial disparity between Whites and African Americans in incidence and outcome of pancreatic cancer: have we made a difference? H Amirian, D Kwon, SM Vickers, A Livingstone, D Jayaweera, AK Saluja, ... Gastroenterology 162 (4), 1346-1348. e3, 2022 | 3 | 2022 |
| Toxicological Aspects of Medical Device Implants PST Shanmugam, L Chokkalingam, P Bakthavachalam Academic Press, 2020 | 3 | 2020 |
| Targeting IRAK4 Signaling in PDAC: Turning the “Cold” Tumors to “Hot” Ones VK Gupta, S Pandey, S Lavania Gastroenterology 162 (7), 1837-1839, 2022 | 1 | 2022 |
| Potential role of the splicing factor SF3B1 in epigenetic regulation and activation of p53 signaling S Deliard, Y Okamoto, J Madzo, S Pandey, J Jelinek, JP Issa Cancer Research 79 (13_Supplement), 4331-4331, 2019 | 1 | 2019 |
| Tu1418 IMPACT OF AGE ON EXPERIMENTAL ACUTE PANCREATITIS AND ITS PROGRESSION HM ISHQI, S Pandey, R Dawra Gastroenterology 164 (6), S-1049, 2023 | | 2023 |
| Role of epigenetics in pancreatic ductal adenocarcinoma SPL Somnath Pandey, Vineet K Gupta Epigenomics (Epub ahead of print), 2023 | | 2023 |
| Su1413 PHOSPHATIDIC ACID MEDIATED CELL SIGNALING REGULATES THE METASTATIC ABILITY OF CD133+ TUMOR INITIATING CELLS IN PANCREATIC CANCER VK Gupta, S Pandey, S Lavania, A Saluja Gastroenterology (New York, NY 1943) 164 (6), S-603-S-603, 2023 | | 2023 |
| CDK9 phosphorylates BRG1 chromatin remodeler S Pandey, H Zhang, CA Barrero, S Merali, X Graña, JP Issa Cancer Research 78 (13_Supplement), 2995-2995, 2018 | | 2018 |
| Abstract A19: A novel MECP2 acetylation site regulates binding with ATRX and HDAC1 S Pandey, GE Simmons Jr, S Malyarchuk, TN Calhoun, K Pruitt Cancer Research 76 (2_Supplement), A19-A19, 2016 | | 2016 |
| Abstract| PDF| Full Text| Supplementary Material| Order a Reprint| https://doi. org/10.18632/genesandcancer. 84 S Pandey, GE Simmons Jr, S Malyarchuk, TN Calhoun, K Pruitt | | |
